Published on in Vol 8 , No 5 (2020) :May

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/16043, first published .
Human-Centered Design Strategies for Device Selection in mHealth Programs: Development of a Novel Framework and Case Study

Human-Centered Design Strategies for Device Selection in mHealth Programs: Development of a Novel Framework and Case Study

Human-Centered Design Strategies for Device Selection in mHealth Programs: Development of a Novel Framework and Case Study

Ashley Marie Polhemus   1, 2 , MSc ;   Jan Novák   1, 3 , MSc ;   Jose Ferrao   1 , PhD ;   Sara Simblett   4 , PhD ;   Marta Radaelli   5 , PhD ;   Patrick Locatelli   6 , PhD ;   Faith Matcham   4, 7 , PhD ;   Maximilian Kerz   4 , PhD ;   Janice Weyer   8 , BA, BSc ;   Patrick Burke   8 , BSc ;   Vincy Huang   9 , MSc ;   Marissa Fallon Dockendorf   10 , PhD ;   Gergely Temesi   1 , PhD ;   Til Wykes   4, 7 , PhD ;   Giancarlo Comi   5 , PhD ;   Inez Myin-Germeys   11 , PhD ;   Amos Folarin   4, 7 , PhD ;   Richard Dobson   4 , PhD ;   Nikolay V Manyakov   12 , PhD ;   Vaibhav A Narayan   13 , PhD ;   Matthew Hotopf   4, 7 , PhD

1 Merck Research Labs Information Technology, Merck Sharpe & Dohme, Prague, Czech Republic

2 Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Zürich, Switzerland

3 Department of Anthropology and Human Genetics, Faculty of Science, Charles University, Prague, Czech Republic

4 Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom

5 Neurology Services, San Raffaele Hospital Multiple Sclerosis Centre, Milan, Italy

6 Department of Engineering and Applied Science, University of Bergamo, Bergamo, Italy

7 National Institute for Health Research, Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, United Kingdom

8 Patient Advisory Board, Remote Assessment of Disease and Relapse Research Program, King's College London, London, United Kingdom

9 Merck Research Labs Information Technology, Merck Sharpe & Dohme, Singapore, Singapore

10 Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Merck & Co, Inc, Kenilworth, NJ, United States

11 Department for Neurosciences, Center for Contextual Psychiatry, Katholieke Universiteit Leuven, Leuven, Belgium

12 Janssen Pharmaceutica NV, Beerse, Belgium

13 Research and Development Information Technology, Janssen Research & Development, LLC, Titusville, NJ, United States

Corresponding Author: